McLean DR, Jacobs H, Mielke BW: Methanol poisoning: A clinical and pathological study. Ann Neurol 8:161, 1980.
Mello NK, Mendelson JH: Buprenorphine treatment of cocaine and heroin abuse. In: Cowan A, Lewis JW (eds): Buprenorphine: Combatting Drug Abuse With a Unique Opioid.
Wilmington, DE, Wiley-Liss, 1995, pp 241–287.
Miles WR: Psychological effects of alcohol and man. In: Emerson H (ed): Alcohol and Man. New York, Macmillan, 1932, p 224.
Monroe JJ, Ross WF, Berzins JI: The decline of the addict as “psychopath”: Implications for community care. Int J Addict 6:601, 1971.
Moretto A, Lotti M: Poisoning by organophosphorus insecticides and sensory polyneuropathy. J Neurol Neurosurg Psychiatry 64:463, 1998.
Moyer TP: Testing for arsenic. Mayo Clin Proc 68:1210, 1993.
Needleman HL, Schell A, Bellinger D, et al: The long-term effects of exposure to low doses of lead in childhood: An 11-year follow-up report. N Engl J Med 322:83, 1990.
Neelapu SS, Tummala S, Kebriaei P, et al: Chimeric antigen receptor T-cell therapy—assessment and management of toxicities. Nat Rev Clin Oncol 15:47, 2018.
Nelson JC: Tricyclic and tetracyclic drugs. In: Schatzberg AF, Nemeroff CB (eds): The American Psychiatric Publishing Textbook of Psychopharmacology, 4th ed. Washington DC,
American Psychiatric Publishing, 2009, p 263.
Nicholi AM: The nontherapeutic use of psychoactive drugs. N Engl J Med 308:925, 1983.
Nierenberg DW, Nordgren RE, Chang MB, et al: Delayed cerebellar disease and death after accidental exposure to dimethylmercury. N Engl J Med 338:1672, 1998.
O’Connor PG, Schottenfeld RS: Patients with alcohol problems. N Engl J Med 338:592, 1998.
Oviedo-Joekes E, Brissette S, Marsh DC, et al: Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 361:777, 2009.
Pearn J: Neurology of ciguatera. J Neurol Neurosurg Psychiatry 70:4, 2001.
Perl DP, Gajdusek DC, Garruto RM, et al: Intraneuronal and parkinsonism-dementia of Guam. Science 217:1053, 1982.
Porjesz B, Begleiter H: Brain dysfunction and alcohol. In:
Kissin B, Begleiter H (eds): The Biology of Alcoholism. Vol 7: The Pathogenesis of Alcoholism. New York, Plenum Press, 1983, pp 415–483.
Postow MA, Sidlow R, Hellman MD: Immune-related adverse events associated with immune checkpoint blockade. N Engl
J Med 378:158, 2018.
Prineas J: The pathogenesis of the dying-back polyneuropathies.
J Neuropathol Exp Neurol 28:571, 1969.